Whoop Hits $10B Valuation, Courts Everyday Health

Whoop, a company specializing in wearable health technology, has recently announced $575 million in new financing, elevating its valuation to $10.1 billion. This significant funding round was led by Collaborative Fund and saw participation from notable investors, including LeBron James and Cristiano Ronaldo.

Initially established in 2012 and branded as a performance enhancement tool for elite athletes, Whoop has broadened its appeal to everyday health trackers. This shift, fueled by the growing interest in biohacking and longevity, has accelerated the company's business growth. Approximately 60 percent of Whoop's sales last year originated from international markets.

The company operates on a subscription model, offering its fitness bands and tracking app for an annual fee. Features include continuous monitoring of heart rate variability, blood pressure, and blood oxygen levels, along with behavioral coaching and health scores. Whoop is also expanding its product line to include medical-grade devices like electrocardiogram tests and is eyeing an initial public offering within the next two years.

As Whoop develops more advanced, medical-grade offerings, it navigates a complex regulatory landscape. Competitors in the wearable tech market include Oura Health, Apple Watch, and Garmin, many of which do not require a monthly subscription fee.